SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001756770-23-000017
Filing Date
2023-11-13
Accepted
2023-11-13 06:06:57
Documents
10
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 6-K q3236-kcover.htm 6-K 20174
2 EX-99.1 q323financialstatements.htm EX-99.1 1064759
3 EX-99.2 q323mda.htm EX-99.2 956389
4 EX-99.3 q323ceocertification.htm EX-99.3 9136
5 EX-99.4 q323cfocertification.htm EX-99.4 9221
6 EX-99.5 q323earningsrelease.htm EX-99.5 410507
7 EX-99.6 q323form5.htm EX-99.6 70958
8 image_01.jpg GRAPHIC 8736
9 image_014.jpg GRAPHIC 31313
10 image_0.jpg GRAPHIC 32432
  Complete submission text file 0001756770-23-000017.txt   2642351
Mailing Address 420 LEXINGTON AVENUE NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE NEW YORK NY 10170 781-451-0117
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 231394665
SIC: 2833 Medicinal Chemicals & Botanical Products